Analysis of relative gene expression in ovaries from 6-month-old obese (ob/ob) females, control (n = 6) or treated with dasatinib plus quercetin (n = 6). A Anti-Mullerian hormone (Amh), (B) chemokine ligand 2 (CCL2), (C) Stanniocalcin-1 (Stc1), (D) Interleukin 1 alpha (IL-1a), (E) growth/differentiation factor 15 (Gdf15), (F) matrix metallopeptidase 12 (Mmp12). Values of P < 0.05 were considered significant